Obesity

Incretin-Based Therapies and Post–Bariatric Surgery Alcohol Use Disorder

JAMA Netw OpenPublished Retrospective cohort study

Main finding · New-onset AUDResult — go to the resultHazard ratio 0.45 95% CI 0.25–0.81

Authors' conclusion

In this cohort study of patients who underwent bariatric surgery, IBT was associated with a 55% lower risk of new-onset AUD and a 41% lower risk of initiation of MAUDs compared with non-IBT AOMs. These findings suggest potential neurobehavioral benefits associated with IBTs that may inform AOM selection in this high-risk population. Prospective studies are warranted to confirm these associations and examine long-term liver-related outcomes.

Study context

Population
Adults who underwent bariatric surgery and subsequently received an AOM between January 1, 2020, and January 1, 2024; US electronic health record network3,990 per group after matching
Participants
15,382 adults
Exposure
IBT vs non-IBT antiobesity medications (AOMs) after bariatric surgery
  • IBTn = 11,194
  • Non-IBTn = 4,188reference
Outcome
Incidence rates (per 1000 person-years) and hazard ratios (HRs) of new-onset alcohol use disorder (AUD) and initiation of MAUDs
Follow-up
Up to 2 years after AOM initiation
Methodological detailspropensity-score matched (1:1), multi-institutional US electronic health record network
  • Propensity-score matched (1:1)
  • Multi-institutional US electronic health record network

Main finding

New-onset AUD

Hazard ratio

0.45

95% CI 0.25–0.81

P = 0.006

By group

IBT

2.4 per 1000 person-years

Non-IBT

5.2 per 1000 person-years

IBTvs Non-IBT
HR 0.45 (95% CI 0.25–0.81); P = 0.006

As reported in the abstract

Observational data: associations, not effects.

Further findings

Per 1000 person-years

OutcomeIBTNon-IBTHR (95% CI)P value
Initiation of MAUDsPropensity-score matched15.225.60.59 (0.46–0.75)P < 0.001

Sensitivity analyses

Results consistent across sensitivity analyses, incl. AOM initiation within 5 years of surgery and ≥3 AOM prescriptions

Original publication

Incretin-Based Therapies and Post–Bariatric Surgery Alcohol Use Disorder. JAMA Netw Open. Published 1 December 2025. doi:10.1001/jamanetworkopen.2025.49086

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.